Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Pasche

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Journal of Cellular Physiology|February 13, 2001
Role of transforming growth factor beta in cancerB Pasche
Comprehensive Therapy|January 1, 1993
An evaluation of the safety of low energy emission therapyD Amato, B Pasche
Platelets|November 4, 2010
Platelets and fibrinolysisB Pasche, J Loscalzo
Best Practice & Research. Clinical Gastroenterology|April 16, 2013
Selecting patients for cytotoxic therapies in gastroenteropancreatic neuroendocrine tumoursF P Costa, B Gumz, B Pasche
Blood|January 15, 1994
Structural changes in platelet glycoprotein IIb/IIIa by plasmin: determinants and functional consequencesB Pasche, H Ouimet, S Francis, et al.
Thrombosis Research|June 1, 1991
Heparin cofactor II significance for the inhibition of thrombin at the injured vessel wallB Pasche, J Swedenborg, S Frebelius, et al.
Thrombosis and Haemostasis|June 28, 1990
The use of a commercial ELISA for assay of thrombin-antithrombin complexes in purified systemsG Elgue, B Pasche, M Blombäck, et al.
Thrombosis and Haemostasis|July 1, 1995
Platelets and plasminogen activationJ Loscalzo, B Pasche, H Ouimet, et al.
Thrombosis Research|December 15, 1986
Thrombin inactivation on surfaces with covalently bonded heparinB Pasche, K Kodama, O Larm, et al.
Artificial Organs|December 1, 1991
Binding of antithrombin to immobilized heparin under varying flow conditionsB Pasche, G Elgue, P Olsson, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Journal of Cellular Physiology|February 13, 2001
Role of transforming growth factor beta in cancerB Pasche
Comprehensive Therapy|January 1, 1993
An evaluation of the safety of low energy emission therapyD Amato, B Pasche
Platelets|November 4, 2010
Platelets and fibrinolysisB Pasche, J Loscalzo
Best Practice & Research. Clinical Gastroenterology|April 16, 2013
Selecting patients for cytotoxic therapies in gastroenteropancreatic neuroendocrine tumoursF P Costa, B Gumz, B Pasche
Blood|January 15, 1994
Structural changes in platelet glycoprotein IIb/IIIa by plasmin: determinants and functional consequencesB Pasche, H Ouimet, S Francis, et al.
Thrombosis Research|June 1, 1991
Heparin cofactor II significance for the inhibition of thrombin at the injured vessel wallB Pasche, J Swedenborg, S Frebelius, et al.
Thrombosis and Haemostasis|June 28, 1990
The use of a commercial ELISA for assay of thrombin-antithrombin complexes in purified systemsG Elgue, B Pasche, M Blombäck, et al.
Thrombosis and Haemostasis|July 1, 1995
Platelets and plasminogen activationJ Loscalzo, B Pasche, H Ouimet, et al.
Thrombosis Research|December 15, 1986
Thrombin inactivation on surfaces with covalently bonded heparinB Pasche, K Kodama, O Larm, et al.
Artificial Organs|December 1, 1991
Binding of antithrombin to immobilized heparin under varying flow conditionsB Pasche, G Elgue, P Olsson, et al.
Pageof 3